Holtappels, R; Bohm, V; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 125-34
Fassbender, M; Herter, S; Holtappels, R et al.
Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 185-9
Cicin-Sain, L; Ruzsics, Z; Podlech, J et al.
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.J Virol. Bd. 82. H. 5. 2008 S. 2056-64
Bohm, V; Podlech, J; Thomas, D et al.
Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 135-44
Mersseman, V; Besold, K; Reddehase, MJ et al.
Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies.J Gen Virol. Bd. 89. H. Pt 2. 2008 S. 369-79
Seckert, CK; Renzaho, A; Reddehase, MJ et al.
Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 251-9
Raftery, MJ; Hitzler, M; Winau, F et al.
Inhibition of CD1 antigen presentation by human cytomegalovirusJOURNAL OF VIROLOGY. Bd. 82. H. 9. 2008 S. 4308-4319
Reddehase, MJ; Simon, CO; Seckert, CK et al.
Murine model of cytomegalovirus latency and reactivation.Curr Top Microbiol Immunol. Bd. 325. 2008 S. 315-31
Wirtz, N; Schader, SI; Holtappels, R et al.
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 151-8
Besold, K; Plachter, B
Recombinant viruses as tools to study human cytomegalovirus immune modulationMed Microbiol Immunol. Bd. 197. H. 2. 2008 S. 215-222
Distler, E; Schnurer, E; Wagner, E et al.
Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.Biol Blood Marrow Transplant. Bd. 14. H. 12. 2008 S. 1417-24
Mersseman, V; Bohm, V; Holtappels, R et al.
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 97-107
Holtappels, R; Simon, CO; Munks, MW et al.
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.J Virol. Bd. 82. H. 12. 2008 S. 5781-96
Bohm, V; Simon, CO; Podlech, J et al.
The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation.J Virol. Bd. 82. H. 23. 2008 S. 11637-50
Sacher, T; Podlech, J; Mohr, CA et al.
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host.Cell Host Microbe. Bd. 3. H. 4. 2008 S. 263-72
Wilhelmi, V; Simon, CO; Podlech, J et al.
Transactivation of Cellular Genes Involved in Nucleotide Metabolism by the Regulatory IE1 Protein of Murine Cytomegalovirus is Not Critical for Viral Replicative Fitness in Quiescent Cells and Host TissuesJ Virol. Bd. 82. H. 20. 2008 S. 9900-16
Simon, CO; Kühnapfel, B; Reddehase, MJ et al.
Murine Cytomegalovirus Major Immediate Early Enhancer Region Operating as a Genetic Switch in Bidirectional Gene Pair TranscriptionJ Virol. Bd. 81. H. 14. 2007 S. 7805-7810
Besold, K; Frankenberg, N; Pepperl-Klindworth, S et al.
Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasionJ Gen Virol. Bd. 88. 2007 S. 1429-1439
Simon, CO; Holtappels, R; Tervo, HM et al.
CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.J Virol. Bd. 80. H. 21. 2006 S. 10436-56
Holtappels, R; Munks, MW; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipientM. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. 1. Aufl. Wymondham, Norfolk, United Kingdom: Caister Academic Press 2006
Pepperl-Klindworth, S; Plachter, B
Current perspectives in vaccine development. Beitrag in: M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunologyCaister Academic Press Wymondham, Norfolk, United Kingdom, 1. Aufl. 2006, S.551-572 2006 551 S.
Holtappels, R; Gillert-Marien, D; Thomas, D et al.
Cytomegalovirus encodes a positive regulator of antigen presentation.J Virol. Bd. 80. H. 15. 2006 S. 7613-24
Pepperl-Klindworth, S; Besold, K; Frankenberg, N et al.
Cytomegalovirus Interleukin-10 Expression in Infected Cells Does Not Impair MHC Class I Restricted Peptide Presentation on Bystanding Antigen-Presenting CellsViral Immunol. Bd. 19. H. 1. 2006 S. 92-101
Simon, CO; Seckert, CK; Grzimek, NKA et al.
Cytomegalovirus Latency and Reactivation: the Silencing/Desilencing and Immune Sensing HypothesisCytomegaloviruses: molecular biology and immunology. 1. Aufl. Norfolk, U.K.: Caister Academic Press 2006
Reddehase, MJ
Cytomegaloviruses: molecular biology and immunologyEditor. 1. Aufl. Norfolk, United Kingdom: Caister Academic Press Wymondham 2006